Jan Gunst1, Greet Van den Berghe2. 1. Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Louvain, Belgium. 2. Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Louvain, Belgium. greet.vandenberghe@med.kuleuven.be.
Authors: Dirk Vlasselaers; Ilse Milants; Lars Desmet; Pieter J Wouters; Ilse Vanhorebeek; Ingeborg van den Heuvel; Dieter Mesotten; Michael P Casaer; Geert Meyfroidt; Catherine Ingels; Jan Muller; Sophie Van Cromphaut; Miet Schetz; Greet Van den Berghe Journal: Lancet Date: 2009-01-26 Impact factor: 79.321
Authors: Björn Ellger; Lies Langouche; Milan Richir; Yves Debaveye; Ilse Vanhorebeek; Tom Teerlink; Paul A Van Leeuwen; Greet Van den Berghe Journal: Intensive Care Med Date: 2008-04-22 Impact factor: 17.440
Authors: Sarah Derde; Ilse Vanhorebeek; Eric-Jan Ververs; Ine Vanhees; Veerle M Darras; Erik Van Herck; Lars Larsson; Greet Van den Berghe Journal: Crit Care Med Date: 2010-02 Impact factor: 7.598
Authors: Dieter Mesotten; Johannes V Swinnen; Frank Vanderhoydonc; Pieter J Wouters; Greet Van den Berghe Journal: J Clin Endocrinol Metab Date: 2004-01 Impact factor: 5.958